Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SCHAUMBURG, Ill., Oct. 20, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced U.S. FDA approval of Bupivacaine Hydrochloride Injection, USP, a local or regional...
-
SCHAUMBURG, Ill., Sept. 30, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced U.S. FDA approval of Clindamycin Injection, USP, an antibiotic used to treat bacterial...
-
SCHAUMBURG, Ill., Sept. 27, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Paclitaxel Injection, USP, a chemotherapy drug, in 30 mg, 100 mg and 300...
-
SCHAUMBURG, Ill., Sept. 16, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced that President, Chief Executive Officer and founder Jeffrey M. Yordon will present at...
-
SCHAUMBURG, Ill., Sept. 6, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced U.S. FDA approval of its Haloperidol Injection, USP, an antipsychotic medication....
-
SCHAUMBURG, Ill., Aug. 31, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a specialty pharmaceutical company, today announced U.S. FDA approval of its Orphenadrine Citrate...
-
SCHAUMBURG, Ill., Aug. 25, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) announced the hiring of Jonathon Singer as its Chief Financial Officer. Mr. Singer, 47, will be...
-
SCHAUMBURG, Ill., Aug. 18, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of vecuronium bromide for injection, a neuromuscular blocking agent, in 10 and...
-
SCHAUMBURG, Ill., Aug. 9, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced financial results for the quarter ended June 30, 2011 and provided a corporate...
-
SCHAUMBURG, Ill., July 27, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced that it will host a teleconference and webcast to discuss second quarter 2011 financial...